Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can AI measure your Baby's size from a photo?

NCT ID NCT07514182

Knowledge-focused Sponsor: Danone Asia Pacific Holdings Pte, Ltd. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether artificial intelligence can accurately estimate the length, weight, and head circumference of newborns and infants up to 6 months old using photos and videos. Researchers will compare AI estimates to standard measurements taken by healthcare professionals in hospital nurseries. The goal is to develop a simpler, less intrusive way to track infant growth.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a non-invasive, camera-based tool for monitoring infant growth in hospitals, reducing the need for physical measurements.
What could go wrong
This is a small, early-stage observational study (60 infants) focused on algorithm development, not a treatment. The AI may not be accurate enough for clinical use, and results may not apply to all infants or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population comprises neonates and infants from birth up to 6 months of age who are admitted to a neonatal intensive care unit (NICU) or special care nursery (SCN). Eligible participants include very preterm, moderate to late preterm, and term infants who meet the study's inclusion criteria and whose parents or legally acceptable representatives provide written informed consent. Participants are enrolled during their NICU/SCN stay and followed prospectively for the duration of their hospitalization, up to a maximum of 10 weeks. The study collects anthropometric measurements and image and video data in conjunction with routine clinical care.

Ages

0 days to 6 months

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Infants up from birth up to 6 months of postnatal age (including neonates) who have been admitted to the NICU or SCN at the time of screening 2. Parent(s) should be able to comprehend the content of the study and be willing for their child to undergo video and photo recording, and to allow access to their blood sampling results (haemoglobin) taken as part of standard clinical practice 3. Written consent from parents and/or legally acceptable representative Exclusion Criteria: 1. Infants who were born with gestational age of less than 28 weeks of gestational age 2. Infants who are intubated (i.e., endotracheal, nasotracheal intubation) at the time of screening 3. The investigator considers for any reason that the participant would not be suitable for the study 4. The participant has an existing medical condition that would prevent standardised measurement of length and/or head circumference e.g. structural abnormality of the lower limbs, orthopaedic conditions, hydrocephalus 5. Employees and/or children/family members or relatives of employees of Danone Global Research \& Innovation Center, Danone Asia Pacific Holdings Pte Ltd, or the participating site

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ai (artificial intelligence) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Ai (artificial intelligence) GROWTH Neonates

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • KK Women's and Children's Hospital

    RECRUITING

    Singapore, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.